메뉴 건너뛰기
Circulation
Volumn 122, Issue 23, 2010, Pages
Response to letters regarding article, "statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity c-reactive protein or dyslipidemia: Results from the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials"
Author keywords

[No Author keywords available]
Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN;
EID: 78650694733     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.967208     Document Type: Letter
Times cited : (1)
References (4)
  • 1
    • 77949397716 scopus 로고    scopus 로고
    • Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: Results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials
    • Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation. 2010;121:1069-1077.
    • (2010) Circulation , vol.121 , pp. 1069-1077
    • Mora, S.1    Glynn, R.J.2    Hsia, J.3    MacFadyen, J.G.4    Genest, J.5    Ridker, P.M.6
  • 2
    • 2342565864 scopus 로고    scopus 로고
    • Drug treatment of hyperlipidemia in women
    • Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA. 2004;291:2243-2252.
    • (2004) JAMA , vol.291 , pp. 2243-2252
    • Walsh, J.M.1    Pignone, M.2
  • 3
    • 70749087459 scopus 로고    scopus 로고
    • Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
    • Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis. Int J Cardiol. 2010;138:25-31.
    • (2010) Int J Cardiol , vol.138 , pp. 25-31
    • Petretta, M.1    Costanzo, P.2    Perrone-Filardi, P.3    Chiariello, M.4
  • 4
    • 77649228312 scopus 로고    scopus 로고
    • Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)
    • Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER). Circ Cardiovasc Qual Outcomes. 2009;2:616-263.
    • (2009) Circ Cardiovasc Qual Outcomes , vol.2 , pp. 616-263
    • Ridker, P.M.1    MacFadyen, J.G.2    Fonseca, F.A.3    Genest, J.4    Gotto, A.M.5    Kastelein, J.J.6    Koenig, W.7    Libby, P.8    Lorenzatti, A.J.9    Nordestgaard, B.G.10    Shepherd, J.11    Willerson, J.T.12    Glynn, R.J.13

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.